Είστε εδώ

New glaucoma drug from a Duke University spinoff has an edge over other treatments

A 12-year-old Duke University spinoff founded by two Duke professors has received regulatory approval for its first drug: once-a-day eye drops for glaucoma patients.

Προτεινόμενα Άρθρα